Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Lewis

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
Antimicrobial Agents and Chemotherapy|November 21, 2018
Preexposure to Isavuconazole Increases the Virulence of <i>Mucorales</i> but Not <i>Aspergillus fumigatus</i> in a <i>Drosophila melanogaster</i> Infection ModelSebastian Wurster, Russell E Lewis, Nathaniel D Albert, et al.
The Journal of Infectious Diseases|March 26, 2021
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated AspergillosisFrederic Lamoth, Russell E Lewis, Thomas J Walsh, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2006
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albuminRussell E Lewis, Nathan P Wiederhold, Randall A Prince, et al.
The Journal of Infectious Diseases|January 11, 2013
Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosisRonen Ben-Ami, Nathaniel D Albert, Russell E Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2009
Phaeohyphomycosis in a tertiary care cancer centerRonen Ben-Ami, Russell E Lewis, Issam I Raad, et al.
International Journal of Antimicrobial Agents|March 3, 2009
Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution studyNikolaos V Sipsas, Russell E Lewis, Issam I Raad, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathwaysNathan P Wiederhold, Dimitrios P Kontoyiannis, Randall A Prince, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2014
Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungalsRussell E Lewis, Guangling Liao, Katherine Young, et al.
The Journal of Infection|April 12, 2019
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignanciesMarta Stanzani, Nicola Vianelli, Michele Cavo, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growthRussell E Lewis, Hsiu-Jung Lo, Issam I Raad, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|November 21, 2018
Preexposure to Isavuconazole Increases the Virulence of <i>Mucorales</i> but Not <i>Aspergillus fumigatus</i> in a <i>Drosophila melanogaster</i> Infection ModelSebastian Wurster, Russell E Lewis, Nathaniel D Albert, et al.
The Journal of Infectious Diseases|March 26, 2021
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated AspergillosisFrederic Lamoth, Russell E Lewis, Thomas J Walsh, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2006
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albuminRussell E Lewis, Nathan P Wiederhold, Randall A Prince, et al.
The Journal of Infectious Diseases|January 11, 2013
Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosisRonen Ben-Ami, Nathaniel D Albert, Russell E Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2009
Phaeohyphomycosis in a tertiary care cancer centerRonen Ben-Ami, Russell E Lewis, Issam I Raad, et al.
International Journal of Antimicrobial Agents|March 3, 2009
Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution studyNikolaos V Sipsas, Russell E Lewis, Issam I Raad, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathwaysNathan P Wiederhold, Dimitrios P Kontoyiannis, Randall A Prince, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2014
Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungalsRussell E Lewis, Guangling Liao, Katherine Young, et al.
The Journal of Infection|April 12, 2019
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignanciesMarta Stanzani, Nicola Vianelli, Michele Cavo, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growthRussell E Lewis, Hsiu-Jung Lo, Issam I Raad, et al.
Pageof 23